As published in pbctoday, on the 26 August ________________________________________________________________________________________________________________
The life sciences sector is the subject of huge investor and developer interest. The risk of disruption to projects, therefore, is an acute one. Simon Harbour, building consultancy partner at Rapleys, looks at how the current building materials crisis is impacting the industry.
Investor appetite in the Life Sciences has surged in recent years. Unlike in other sectors, the pandemic has been a catalyst for significant investment including real estate and infrastructure, such as labs and research hubs as well as logistics and back-office facilities.